BiotechTube
Home/Pipeline/ConvergeAB™ Cetuximab Biobetter

ConvergeAB™ Cetuximab Biobetter

EGFR‑positive solid tumors

PreclinicalActive

Key Facts

Indication
EGFR‑positive solid tumors
Phase
Preclinical
Status
Active
Company
Converge Bio

About Converge Bio

AI‑powered platform that designs and optimizes biologics and targets to speed up early drug discovery.

View full company profile

Therapeutic Areas

OncologyImmunologyProtein Therapeutics